Blood Oxygen Level Dependent Magnetic Resonance Imaging (BOLD MRI) and Fluorothymidine Positron Emission Tomography (FLT PET) in Patients With Locally Advanced Breast Cancer Undergoing Neoadjuvant Chemotherapy

Clinical trial NCT01240681 · COMPLETED

Trial details

NCT number: NCT01240681
Sponsor: Ontario Clinical Oncology Group (OCOG)
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Locally Advanced Breast Cancer (LABC)

Start date: 2011-04-01
Primary completion: 2015-01-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.